FDA Inspection 1250729 — Hubei JXBio Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei JXBio Pharmaceutical Co., Ltd. on Aug 30, 2024 in Xianning. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Xianning (China)